Trudey Nicklee

1.7k total citations
20 papers, 1.4k citations indexed

About

Trudey Nicklee is a scholar working on Molecular Biology, Biochemistry and Cancer Research. According to data from OpenAlex, Trudey Nicklee has authored 20 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Biochemistry and 6 papers in Cancer Research. Recurrent topics in Trudey Nicklee's work include Cancer, Hypoxia, and Metabolism (5 papers), Sulfur Compounds in Biology (5 papers) and Glutathione Transferases and Polymorphisms (4 papers). Trudey Nicklee is often cited by papers focused on Cancer, Hypoxia, and Metabolism (5 papers), Sulfur Compounds in Biology (5 papers) and Glutathione Transferases and Polymorphisms (4 papers). Trudey Nicklee collaborates with scholars based in Canada, United States and India. Trudey Nicklee's co-authors include David W. Hedley, Ming‐Sound Tsao, Simon S.M. Ng, Sylvia S. W. Ng, Lillian L. Siu, Amit M. Oza, Janet Dancey, Gregory R. Pond, Jcm Ho and Limei Sun and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and American Journal Of Pathology.

In The Last Decade

Trudey Nicklee

20 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Trudey Nicklee Canada 15 739 566 375 334 231 20 1.4k
Heikki J. Helin Finland 25 574 0.8× 1.0k 1.8× 503 1.3× 571 1.7× 87 0.4× 38 2.1k
Justin H. Hwang United States 15 434 0.6× 393 0.7× 184 0.5× 154 0.5× 134 0.6× 66 922
Maria Gabriela Raso United States 22 1.0k 1.4× 930 1.6× 822 2.2× 444 1.3× 155 0.7× 59 2.0k
Omar Eton United States 26 1.9k 2.6× 1.3k 2.3× 288 0.8× 140 0.4× 186 0.8× 69 2.6k
Tim Dekker Netherlands 17 583 0.8× 407 0.7× 183 0.5× 442 1.3× 49 0.2× 30 1.3k
F. Spyratos France 23 1.0k 1.4× 906 1.6× 228 0.6× 796 2.4× 91 0.4× 52 2.0k
Nikita Makretsov Canada 14 593 0.8× 682 1.2× 164 0.4× 380 1.1× 95 0.4× 19 1.4k
A.L. Børresen-Dale Norway 20 970 1.3× 1.5k 2.6× 295 0.8× 762 2.3× 84 0.4× 41 2.4k
Lydia Gaba Spain 13 786 1.1× 516 0.9× 364 1.0× 487 1.5× 73 0.3× 47 1.4k
Estela Pineda Spain 16 669 0.9× 624 1.1× 354 0.9× 692 2.1× 70 0.3× 65 1.6k

Countries citing papers authored by Trudey Nicklee

Since Specialization
Citations

This map shows the geographic impact of Trudey Nicklee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Trudey Nicklee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Trudey Nicklee more than expected).

Fields of papers citing papers by Trudey Nicklee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Trudey Nicklee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Trudey Nicklee. The network helps show where Trudey Nicklee may publish in the future.

Co-authorship network of co-authors of Trudey Nicklee

This figure shows the co-authorship network connecting the top 25 collaborators of Trudey Nicklee. A scholar is included among the top collaborators of Trudey Nicklee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Trudey Nicklee. Trudey Nicklee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Agulnik, Mark, Gilda da Cunha Santos, David W. Hedley, et al.. (2007). Predictive and Pharmacodynamic Biomarker Studies in Tumor and Skin Tissue Samples of Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated With Erlotinib. Journal of Clinical Oncology. 25(16). 2184–2190. 62 indexed citations
2.
Townsley, Carol, Pierre Major, Lillian L. Siu, et al.. (2006). Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer. British Journal of Cancer. 94(8). 1136–1143. 114 indexed citations
3.
Durán, Ignacio, Jeremy Kortmansky, Deepti Singh, et al.. (2006). A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas. British Journal of Cancer. 95(9). 1148–1154. 260 indexed citations
4.
Li, Tong, Limei Sun, Naomi Miller, et al.. (2005). The Association of Measured Breast Tissue Characteristics with Mammographic Density and Other Risk Factors for Breast Cancer. Cancer Epidemiology Biomarkers & Prevention. 14(2). 343–349. 257 indexed citations
5.
Mackay, Helen, David W. Hedley, Pierre Major, et al.. (2005). A Phase II Trial with Pharmacodynamic Endpoints of the Proteasome Inhibitor Bortezomib in Patients with Metastatic Colorectal Cancer. Clinical Cancer Research. 11(15). 5526–5533. 88 indexed citations
6.
Nicklee, Trudey, et al.. (2005). A high-resolution MACROscope with differential phase contrast, transmitted light, confocal fluorescence, and hyperspectral capabilities for large-area tissue imaging. IEEE Journal of Selected Topics in Quantum Electronics. 11(4). 766–777. 18 indexed citations
7.
8.
Nicklee, Trudey, et al.. (2004). MACROscopic imaging of tumor xenografts using fluorescence, phase contrast, and transmitted light. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 5578. 149–149. 1 indexed citations
9.
Hedley, David W., Trudey Nicklee, Melania Pintilie, et al.. (2004). Relations between non–protein sulfydryl levels in the nucleus and cytoplasm, tumor oxygenation, and clinical outcome of patients with uterine cervical carcinoma. International Journal of Radiation Oncology*Biology*Physics. 61(1). 137–144. 7 indexed citations
10.
Vukovic, Vojislav, Trudey Nicklee, & David W. Hedley. (2002). Multiparameter fluorescence mapping of nonprotein sulfhydryl status in relation to blood vessels and hypoxia in cervical carcinoma xenografts. International Journal of Radiation Oncology*Biology*Physics. 52(3). 837–843. 5 indexed citations
11.
Ng, Sylvia S. W., Ming‐Sound Tsao, Trudey Nicklee, & David W. Hedley. (2002). Effects of the epidermal growth factor receptor inhibitor OSI-774, Tarceva, on downstream signaling pathways and apoptosis in human pancreatic adenocarcinoma.. PubMed. 1(10). 777–83. 149 indexed citations
12.
Ng, Simon S.M., Ming‐Sound Tsao, Trudey Nicklee, & David W. Hedley. (2001). Wortmannin inhibits pkb/akt phosphorylation and promotes gemcitabine antitumor activity in orthotopic human pancreatic cancer xenografts in immunodeficient mice.. PubMed. 7(10). 3269–75. 166 indexed citations
13.
Vukovic, Vojislav, et al.. (2001). Hypoxia-inducible factor-1alpha is an intrinsic marker for hypoxia in cervical cancer xenografts.. PubMed. 61(20). 7394–8. 82 indexed citations
14.
Vukovic, Vojislav, et al.. (2001). Imaging of whole tumor cut sections using a novel scanning beam confocal fluorescence MACROscope®. Journal of Biomedical Optics. 6(3). 326–326. 4 indexed citations
15.
Vukovic, Vojislav, Trudey Nicklee, & David W. Hedley. (2001). Differential effects of buthionine sulphoximine in hypoxic and non-hypoxic regions of human cervical carcinoma xenografts. Radiotherapy and Oncology. 60(1). 69–73. 22 indexed citations
16.
Nicklee, Trudey, et al.. (2000). Microregional heterogeneity of non-protein thiols in cervical carcinomas assessed by combined use of HPLC and fluorescence image analysis.. PubMed. 6(5). 1826–32. 24 indexed citations
17.
Nicklee, Trudey, et al.. (1999). Association between tissue hypoxia and elevated non-protein sulphydryl concentrations in human cervical carcinoma xenografts. British Journal of Cancer. 81(6). 989–993. 19 indexed citations
18.
Tsao, Ming‐Sound, Ni Liu, Trudey Nicklee, Frances A. Shepherd, & Jean Viallet. (1997). Angiogenesis correlates with vascular endothelial growth factor expression but not with Ki-ras oncogene activation in non-small cell lung carcinoma.. PubMed. 3(10). 1807–14. 42 indexed citations
19.
Nicklee, Trudey, Michael Crump, & David W. Hedley. (1996). Effects of topoisomerase I inhibition on the expression of topoisomerase IIα measured with fluorescence image cytometry. Cytometry. 25(3). 205–210. 11 indexed citations
20.
Thomas, Michaël, Trudey Nicklee, & David W. Hedley. (1995). Differential effects of depleting agents on cytoplasmic and nuclear non-protein sulphydryls: a fluorescence image cytometry study. British Journal of Cancer. 72(1). 45–50. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026